CALLIE BLANCO: Open Payments
NPI 1245729573 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 20 payments from 9 companies in 2025. Trend: 2023 $385 · 2024 $406 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $86 |
| SCPHARMACEUTICALS INC. | 3 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Amgen Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: LifeVest, FUROSCIX, JARDIANCE, REPATHA, CARDIOMEMS, LEQVIO, Kerendia, FARXIGA.
Industry payments across FL — which companies pay providers there.
